Last €0.39 EUR
Change Today -0.001 / -0.26%
Volume 8.3K
COF On Other Exchanges
Symbol
Exchange
Berlin
BrsaItaliana
As of 7:46 AM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger Abravanel

AgeTotal Calculated CompensationThis person is connected to 68 board members in 7 different organizations across 7 different industries.

See Board Relationships
68--

Background*

Mr. Roger Abravanel serves as an Advisor to public and private Italian institutions. Mr. Abravanel is an Investment-Partner in an Italian buy-out fund focused on family businesses. He served as a Business Advisor of Clessidra SGR S.p.A. and served there from 2008 to 2011. Mr. Abravanel held many leadership positions in industry practice groups, including the global private equity practice and the specialty chemicals/pharmaceuticals practice. He served as a Senior Advisor ...

Read Full Background

Corporate Headquarters*

Via Ciovassino 1
Milano, Milan 20121

Italy

Phone: 39 02 722701
Fax: 39 02 72 27 02 70

Board Members Memberships*

Director
Former Director
Director
Director
2006-N/A
Former Independent Director and Member of Human Resources Committee
2007-Present
Director and Member of Human Resources & Compensation Committee
2009-N/A
Director
2012-Present
Non-Executive Director and Member of Remuneration Committee

Education*

MBA 1972
INSEAD
Unknown/Other Education 1968
Politecnico di Milano

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COF:IM €0.39 EUR -0.001

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COFIDE SPA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.